Acurx Pharmaceuticals, Inc. (ACXP) vs Lunai Bioworks Inc. (LNAI)

A side-by-side comparison of Acurx Pharmaceuticals, Inc. and Lunai Bioworks Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Acurx Pharmaceuticals, Inc. logo
ACXP
Acurx Pharmaceuticals, Inc.
$6M
$1.29HealthcareDelayed quote: Oct 6, 2026, 10:44 AM EDT
Lunai Bioworks Inc. logo
LNAI
Lunai Bioworks Inc.
$5M
$1.15HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT

Total return — ACXP vs LNAI

growth of $100 · dividends reinvested · last 1y
ACXP -70.0% (-70.0%/yr)LNAI -93.8% (-93.8%/yr)ACXP compounded faster over this window
050100150200Start $1002026$30$6
ACXP LNAI

ACXP vs LNAI: by the numbers

  • •ACXP is the larger company ($6M vs $5M market cap).
  • •Both run net losses; ACXP's is the smaller (0.00% vs -612568.11% net margin).

Metrics side by side

Valuation

MetricACXPLNAI
P/S ratioN/A247.89
P/B ratio0.68N/A

Profitability

MetricACXPLNAI
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%-612568.11%
ROE-92.08%N/A
ROIC-94.08%N/A

Growth (annualized)

MetricACXPLNAI
Total return CAGR (5Y)-57.41%N/A

Go deeper

Full ACXP analysisFull LNAI analysisInteractive comparison tool

Dig into the metrics

Acurx Pharmaceuticals ROELunai Bioworks ROEAcurx Pharmaceuticals operating marginLunai Bioworks operating marginAcurx Pharmaceuticals revenue growthLunai Bioworks revenue growthAcurx Pharmaceuticals free cash flowLunai Bioworks free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.